Cargando…
Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis
PURPOSE: In this study, we present the treatment of the psoriatic nail beds of patients refractory to standard therapies using high-dose-rate (HDR) brachytherapy. The custom-made micro applicators (CMMA) were designed and constructed for radiation dose delivery to small curvy targets with complicate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509984/ https://www.ncbi.nlm.nih.gov/pubmed/28725251 http://dx.doi.org/10.5114/jcb.2017.68304 |
_version_ | 1783250107354841088 |
---|---|
author | Buzurovic, Ivan M. O’Farrell, Desmond A. Bhagwat, Mandar S. Hansen, Jorgen L. Harris, Thomas C. Friesen, Scott Cormack, Robert A. Devlin, Phillip M. |
author_facet | Buzurovic, Ivan M. O’Farrell, Desmond A. Bhagwat, Mandar S. Hansen, Jorgen L. Harris, Thomas C. Friesen, Scott Cormack, Robert A. Devlin, Phillip M. |
author_sort | Buzurovic, Ivan M. |
collection | PubMed |
description | PURPOSE: In this study, we present the treatment of the psoriatic nail beds of patients refractory to standard therapies using high-dose-rate (HDR) brachytherapy. The custom-made micro applicators (CMMA) were designed and constructed for radiation dose delivery to small curvy targets with complicated topology. The role of the HDR brachytherapy treatment was to stimulate the T cells for an increased immune response. MATERIAL AND METHODS: The patient diagnosed with psoriatic nail beds refractory to standard therapies received monthly subunguinal injections that caused significant pain and discomfort in both hands. The clinical target was defined as the length from the fingertip to the distal interphalangeal joint. For the accurate and reproducible setup in the multi-fractional treatment delivery, the CMMAs were designed. Five needles were embedded into the dense plastic mesh and covered with 5 mm bolus material for each micro applicator. Five CMMAs were designed, resulting in the usage of 25 catheters in total. RESULTS: The prescription dose was planned to the depth of the anterior surface of the distal phalanx, allowing for the sparing of the surrounding tissue. The total number of the active dwell positions was 145 with step size of 5 mm. The total treatment time was 115 seconds with a 7.36 Ci activity of the (192)Ir source. The treatment resulted in good pain control. The patient did not require further injections to the nail bed. After this initial treatment, additional two patients with similar symptoms received HDR brachytherapy. The treatment outcome was favorable in all cases. CONCLUSIONS: The first HDR brachytherapy treatment of psoriasis of the nail bed is presented. The initial experience revealed that brachytherapy treatment was well-tolerated and resulted in adequate control of the disease. A larger cohort of patients will be required for additional conclusions related to the long-term clinical benefits. |
format | Online Article Text |
id | pubmed-5509984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-55099842017-07-19 Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis Buzurovic, Ivan M. O’Farrell, Desmond A. Bhagwat, Mandar S. Hansen, Jorgen L. Harris, Thomas C. Friesen, Scott Cormack, Robert A. Devlin, Phillip M. J Contemp Brachytherapy Original Paper PURPOSE: In this study, we present the treatment of the psoriatic nail beds of patients refractory to standard therapies using high-dose-rate (HDR) brachytherapy. The custom-made micro applicators (CMMA) were designed and constructed for radiation dose delivery to small curvy targets with complicated topology. The role of the HDR brachytherapy treatment was to stimulate the T cells for an increased immune response. MATERIAL AND METHODS: The patient diagnosed with psoriatic nail beds refractory to standard therapies received monthly subunguinal injections that caused significant pain and discomfort in both hands. The clinical target was defined as the length from the fingertip to the distal interphalangeal joint. For the accurate and reproducible setup in the multi-fractional treatment delivery, the CMMAs were designed. Five needles were embedded into the dense plastic mesh and covered with 5 mm bolus material for each micro applicator. Five CMMAs were designed, resulting in the usage of 25 catheters in total. RESULTS: The prescription dose was planned to the depth of the anterior surface of the distal phalanx, allowing for the sparing of the surrounding tissue. The total number of the active dwell positions was 145 with step size of 5 mm. The total treatment time was 115 seconds with a 7.36 Ci activity of the (192)Ir source. The treatment resulted in good pain control. The patient did not require further injections to the nail bed. After this initial treatment, additional two patients with similar symptoms received HDR brachytherapy. The treatment outcome was favorable in all cases. CONCLUSIONS: The first HDR brachytherapy treatment of psoriasis of the nail bed is presented. The initial experience revealed that brachytherapy treatment was well-tolerated and resulted in adequate control of the disease. A larger cohort of patients will be required for additional conclusions related to the long-term clinical benefits. Termedia Publishing House 2017-06-13 2017-06 /pmc/articles/PMC5509984/ /pubmed/28725251 http://dx.doi.org/10.5114/jcb.2017.68304 Text en Copyright: © 2017 Termedia Sp. z o. o http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Buzurovic, Ivan M. O’Farrell, Desmond A. Bhagwat, Mandar S. Hansen, Jorgen L. Harris, Thomas C. Friesen, Scott Cormack, Robert A. Devlin, Phillip M. Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title | Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title_full | Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title_fullStr | Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title_full_unstemmed | Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title_short | Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
title_sort | custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509984/ https://www.ncbi.nlm.nih.gov/pubmed/28725251 http://dx.doi.org/10.5114/jcb.2017.68304 |
work_keys_str_mv | AT buzurovicivanm custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT ofarrelldesmonda custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT bhagwatmandars custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT hansenjorgenl custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT harristhomasc custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT friesenscott custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT cormackroberta custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis AT devlinphillipm custommademicroapplicatorsforhighdoseratebrachytherapytreatmentofchronicpsoriasis |